Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Business Of Biotech
00:00
The Transition to a CMO Environment
Liberty is in this transition as Andreas described from being ready with development for some point and then going out now with products into the clinical development world. This is a turning point of the company and I'm very happy to see how now still the same team now expands with internal and external expansions help from outside. For the record if BB Tech or Sartorius want to talk with me about licensing or trademarking the word underglow bioreactor just have your lawyers get in touch with my lawyers and we'll take that conversationAndreas: We've been warmly embraced and and welcomed by all the authorities after they had certain questions which is their job and which they have to ask about measures
Transcript
Play full episode
